ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,529Medicare Part D Prescriptions Filled, Including Refills

Rank: 545 out of 1454

$552K Total Retail Price of All Prescriptions

Rank: 367 out of 1454

344 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 344 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 5,337 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 334 225 1 1
OMEPRAZOLE 230 140 2 3
GABAPENTIN 192 93 3 16
LISINOPRIL 140 104 4 4
LEVOTHYROXINE SODIUM 131 110 5 5
RAMIPRIL 126 116 6 66
LOSARTAN POTASSIUM 123 114 7 14
CRESTOR 121 99 8 22
AMLODIPINE BESYLATE 119 111 9 2
SERTRALINE HCL 115 78 10 26
HYDROCHLOROTHIAZIDE 115 68 10 9
POTASSIUM CHLORIDE 115 99 10 15
ATORVASTATIN CALCIUM 114 80 13 11
METOPROLOL SUCCINATE 113 74 14 13
FUROSEMIDE 106 86 15 6
ATENOLOL 104 78 16 18
PREDNISONE 94 65 17 36
METFORMIN HCL ER 86 55 18 41
LOSARTAN-HYDROCHLOROTHIAZIDE 81 70 19 38
HYDROCODONE-ACETAMINOPHEN 80 61 S3 20 7
TRAMADOL HCL 74 45 21 20
AMITRIPTYLINE HCL 73 61 R 22 71
WARFARIN SODIUM 72 61 23 17
VENLAFAXINE HCL ER 72 35 23 105
TRAZODONE HCL 67 49 25 50
DILTIAZEM 24HR CD 66 50 26 76
DIOVAN 65 63 27 40
DOXEPIN HCL 65 44 27 234
ADVAIR DISKUS 62 53 29 47
DILTIAZEM 24HR ER 61 45 30 120
CYMBALTA 61 52 30 55
LANTUS SOLOSTAR 59 26 32 79
ALENDRONATE SODIUM 59 37 32 35
AZITHROMYCIN 58 36 34 42
KLOR-CON M20 55 36 35 54
SPIRIVA 55 34 35 52
FLUOXETINE HCL 54 29 37 72
ISOSORBIDE MONONITRATE ER 53 48 38 46
BUMETANIDE 52 46 39 149
NEXIUM 51 34 40 23
MIRTAZAPINE 51 50 40 53
POLYETHYLENE GLYCOL 3350 51 28 40 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.